Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie J Si Lim

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pediatric Blood & Cancer|June 1, 2021
Tisagenlecleucel for treatment of children and young adults with relapsed/refractory B-cell acute lymphoblastic leukemiaStephanie J Si Lim, Stephen A Grupp, Amanda M DiNofia
Blood|April 5, 2023
How I treat newly diagnosed and refractory T-cell acute lymphoblastic lymphoma in children and young adultsStephanie J Si Lim, James B Ford, Michelle L Hermiston
Cancers|May 13, 2026
An Integrated Academic Oncology Ecosystem for Hawai'i and the U.S.-Affiliated Pacific IslandsStephanie J Si Lim, Hideko Yamauchi, Teruo Yamauchi, et al.
JCO Oncology Practice|September 24, 2025
Benchmarking the Current Landscape: Insights From an Association of American Cancer Institutes Survey on Academic Cancer Service LinesPaula M Fracasso, Nicole L Simone, Stephanie J Si Lim, et al.
Blood Advances|March 1, 2023
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALLKevin O McNerney, Stephanie J Si Lim, Kyle Ishikawa, et al.
Blood|August 10, 2023
Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGDJennifer W Leiding, Danielle E Arnold, Suhag Parikh, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pediatric Blood & Cancer|June 1, 2021
Tisagenlecleucel for treatment of children and young adults with relapsed/refractory B-cell acute lymphoblastic leukemiaStephanie J Si Lim, Stephen A Grupp, Amanda M DiNofia
Blood|April 5, 2023
How I treat newly diagnosed and refractory T-cell acute lymphoblastic lymphoma in children and young adultsStephanie J Si Lim, James B Ford, Michelle L Hermiston
Cancers|May 13, 2026
An Integrated Academic Oncology Ecosystem for Hawai'i and the U.S.-Affiliated Pacific IslandsStephanie J Si Lim, Hideko Yamauchi, Teruo Yamauchi, et al.
JCO Oncology Practice|September 24, 2025
Benchmarking the Current Landscape: Insights From an Association of American Cancer Institutes Survey on Academic Cancer Service LinesPaula M Fracasso, Nicole L Simone, Stephanie J Si Lim, et al.
Blood Advances|March 1, 2023
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALLKevin O McNerney, Stephanie J Si Lim, Kyle Ishikawa, et al.
Blood|August 10, 2023
Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGDJennifer W Leiding, Danielle E Arnold, Suhag Parikh, et al.
Pageof 1